Jennifer Hodge
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Jennifer Hodge
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases
33
| Extinct | Biotechnology | 33 |
Nile Therapeutics, Inc. /Old/
8
| Extinct | Pharmaceuticals: Major | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jennifer Hodge tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director of Finance/CFO President Director/Board Member Director/Board Member Treasurer Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Founder General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Director/Board Member | |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Director/Board Member Chairman Corporate Officer/Principal | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Founder Treasurer | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Private Equity Investor | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Investment Managers | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| Orion Biomedical Fund LP | Corporate Officer/Principal Chief Investment Officer Corporate Officer/Principal | ||
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Comptroller/Controller/Auditor | |
| KITE PHARMA INC | Biotechnology | Founder Founder Comptroller/Controller/Auditor | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CODEXIS, INC. | Chemicals: Specialty | Chief Executive Officer Chief Administrative Officer | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Specialty Renal Products, Inc.
 Specialty Renal Products, Inc. Medical SpecialtiesHealth Technology Specialty Renal Products, Inc. develops medical devices for patients with renal diseases. The firm focuses on the development of products for patients with renal disease, including a hemodiafiltration (HDF) system for the treatment of patients with End Stage Renal Disease (ESRD). The company was founded in 2018 and is headquartered in Nashville, TN. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| NEPHROS, INC. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| RESVERLOGIX CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Amygdala Neurosciences, Inc.
 Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Human Resources Officer General Counsel | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| University of London | College/University | Graduate Degree Doctorate Degree | |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Chairman Director/Board Member | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| XOMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
| The University of Texas at Austin | College/University | Doctorate Degree Corporate Officer/Principal | |
| Two River Group Management LLC | Director/Board Member President | ||
| Two Rivers Consulting Corp. | Corporate Officer/Principal Director of Finance/CFO | ||
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 47 |
| Regno Unito | 3 |
| Canada | 2 |
| Svezia | 2 |
Settori
| Health Technology | 33 |
| Consumer Services | 10 |
| Finance | 4 |
| Process Industries | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 262 |
| Corporate Officer/Principal | 127 |
| Independent Dir/Board Member | 50 |
| Founder | 37 |
| Undergraduate Degree | 33 |
Contatti più connessi
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Joshua Kazam | 43 |
| Kenneth Lee | 40 |
| Peter Morgan Kash | 32 |
| Santo Costa | 28 |
| David Tanen | 25 |
| Cam Gallagher | 24 |
| R. Greer | 23 |
| Anders Waas | 21 |
| Thomas Shenk | 21 |
| Paul Anthony Mieyal | 18 |
| Joseph M. Davie | 17 |
| Bruce Philip Pritchard | 15 |
| Daron Evans | 15 |
| Kenneth F. Boehm | 12 |
- Borsa valori
- Insiders
- Jennifer Hodge
- Connessioni Società
